Details of the Drug

General Information of Drug (ID: DM6ZNX4)

• Drug Name: RGN-352
• Synonyms: Thymosin Beta 4 (injectable)

Indication

Disease Entry	ICD 11	Status	REF
Acute myocardial infarction	BA41	Phase 2	[1]
Myocardial infarction	BA41-BA43	Phase 2	[1]
Peripheral neuropathy	8C0Z	Phase 1	[2]
Stroke	8B20	Phase 1	[3]

• Drug Type: Peptide
• Cross-matching ID: TTD ID: DU04SO
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01311518) A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)